Brett Sandercock - Nov 16, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Stock symbol
RMD
Transactions as of
Nov 16, 2021
Transactions value $
$5,187,932
Form type
4
Date filed
11/18/2021, 04:41 PM
Previous filing
Nov 12, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $5.19M +20.4K +24% $254.81 105K Nov 16, 2021 Direct F1
transaction RMD ResMed Common Stock Award $0 +1.16K +1.1% $0.00 106K Nov 18, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
F2 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.